IRIS
PLANTONE, DOMENICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.796
EU - Europa 4.477
AS - Asia 3.371
SA - Sud America 923
Continente sconosciuto - Info sul continente non disponibili 413
AF - Africa 318
OC - Oceania 8
Totale 14.306
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.674
IT - Italia 1.427
SG - Singapore 1.158
RU - Federazione Russa 1.051
CN - Cina 797
BR - Brasile 757
IE - Irlanda 660
VN - Vietnam 400
FR - Francia 320
HK - Hong Kong 312
SE - Svezia 289
BD - Bangladesh 200
GB - Regno Unito 200
ZA - Sudafrica 150
KR - Corea 134
DE - Germania 126
ES - Italia 105
FI - Finlandia 97
IN - India 92
NG - Nigeria 85
AR - Argentina 62
CA - Canada 56
NL - Olanda 49
IQ - Iraq 45
ID - Indonesia 34
EC - Ecuador 31
MX - Messico 31
KE - Kenya 28
TR - Turchia 27
AT - Austria 26
SA - Arabia Saudita 26
JP - Giappone 24
PK - Pakistan 20
BE - Belgio 18
CL - Cile 17
CO - Colombia 14
CZ - Repubblica Ceca 14
UA - Ucraina 14
CH - Svizzera 13
PL - Polonia 13
PY - Paraguay 12
VE - Venezuela 12
LT - Lituania 10
AE - Emirati Arabi Uniti 9
EG - Egitto 8
IR - Iran 8
MA - Marocco 8
TN - Tunisia 8
UZ - Uzbekistan 8
AL - Albania 7
AU - Australia 7
DZ - Algeria 7
JO - Giordania 7
PE - Perù 7
TT - Trinidad e Tobago 7
AZ - Azerbaigian 6
IL - Israele 6
KZ - Kazakistan 6
MY - Malesia 6
DK - Danimarca 5
HU - Ungheria 5
NP - Nepal 5
PT - Portogallo 5
RO - Romania 5
SC - Seychelles 5
UY - Uruguay 5
AM - Armenia 4
CI - Costa d'Avorio 4
CR - Costa Rica 4
JM - Giamaica 4
NI - Nicaragua 4
PH - Filippine 4
PS - Palestinian Territory 4
RS - Serbia 4
SN - Senegal 4
TH - Thailandia 4
BO - Bolivia 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GE - Georgia 3
GT - Guatemala 3
HN - Honduras 3
LB - Libano 3
QA - Qatar 3
BG - Bulgaria 2
GR - Grecia 2
GY - Guiana 2
KG - Kirghizistan 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MU - Mauritius 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TG - Togo 2
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
Totale 13.872
Salva come PNG Salva come JPEG
Città #
Dallas 1.034
Dublin 643
Singapore 538
Milan 496
Santa Clara 396
Chandler 378
Hong Kong 295
Moscow 285
Council Bluffs 274
Hefei 219
Ashburn 209
San Jose 185
Beijing 170
Princeton 165
Fairfield 143
Ho Chi Minh City 140
Johannesburg 140
Seoul 134
Rome 127
Los Angeles 111
Hanoi 105
Lauterbourg 105
Southend 88
Málaga 87
Wilmington 87
New York 84
Abuja 81
São Paulo 67
Helsinki 59
Columbus 57
Siena 51
Buffalo 48
Seattle 47
Redondo Beach 46
Florence 45
Houston 42
Figino 35
San Diego 35
Woodbridge 35
Ann Arbor 29
Bengaluru 29
Frankfurt am Main 29
Nuremberg 29
Lappeenranta 28
The Dalles 28
Cambridge 26
London 26
Naples 24
Chicago 23
Orem 22
Atlanta 21
Lucca 21
Munich 21
Pisa 21
Baghdad 20
Belo Horizonte 20
Turin 20
Bologna 18
Riyadh 18
Toronto 18
Chennai 16
Haiphong 16
Palermo 15
Brussels 14
Messina 14
Brno 13
Brooklyn 13
Livorno 13
Phoenix 13
Quito 13
Rio de Janeiro 13
San Francisco 13
Shanghai 13
Tokyo 13
Boston 12
Nairobi 12
Bari 11
Biên Hòa 11
Campinas 11
City of London 11
Da Nang 11
Goiânia 11
Guangzhou 11
Porto Alegre 11
Vienna 10
Basingstoke 9
Curitiba 9
Genoa 9
Brasília 8
Istanbul 8
Jakarta 8
Memphis 8
Turku 8
Warsaw 8
Amman 7
Aracaju 7
Carlentini 7
Fortaleza 7
Jacksonville 7
Montreal 7
Totale 8.208
Salva come PNG Salva come JPEG
Nome #
An atypical case of Creutzfeldt-Jakob disease mimicking frontotemporal dementia: genotypic influence and clinical implications 487
Vitamin D in neurological diseases 287
Elevated serum concentrations of GFAP in hereditary transthyretin amyloidosis since pre-symptomatic stages 198
Brain neuronal and glial damage during acute COVID-19 infection in absence of clinical neurological manifestations 195
Hippocampal atrophy and white matter lesions characteristics can predict evolution to dementia in patients with vascular mild cognitive impairment 188
Neurofilament light chain and glial fibrillary acid protein levels are elevated in post-mild COVID-19 or asymptomatic SARS-CoV-2 cases 184
Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis 182
Interferon-β therapy and risk of thrombocytopenia in multiple sclerosis patients 179
B Lymphocytes in Alzheimer's Disease-A Comprehensive Review 173
[18F]FDG PET metabolic correlates of cerebrospinal fluid TAR DNA-binding protein 43 in prodromal Alzheimer's disease 168
A Systematic Review Focusing on the Link between Engineered Nanoparticles and Neurodegeneration 164
Neurological diseases associated with autoantibodies targeting the voltage-gated potassium channel complex: immunobiology and clinical characteristics 162
Peripherin, a new promising biomarker in neurological disorders 157
Does Lumbar Puncture Still Have Clinical Value for Patients with Amyotrophic Lateral Sclerosis? 156
CSF IL-6, GDF-15, GFAP and NfL levels in early Alzheimer disease: a pilot study 156
Comparative Analysis of SiMoA and Ella Immunoassay Platforms for Measuring Serum Neurofilament Light Chain Levels in ATTRv With Polyneuropathy and Presymptomatic Carriers 151
Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosis 151
Acute Necrotizing Encephalopathy during Novel Influenza A (H1N1) Virus Infection 150
A neurometabolic profile of SPMS: the relationship between brain metabolites and clinical disability 144
Anti-annexin antibodies, cholesterol levels and disability in multiple sclerosis 143
Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome 142
Amiloride, Fluoxetine or Riluzole to Reduce Brain Volume Loss in Secondary Progressive Multiple Sclerosis: The MS-SMART Four-Arm RCT 142
A voxel-based lesion symptom mapping analysis of chronic pain in multiple sclerosis 140
A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis 140
Progress in the Treatment of Alzheimer’s Disease Is Needed – Position Statement of European Alzheimer’s Disease Consortium (EADC) Investigators 139
Insights into the role of cerebrospinal fluid cytokines in Alzheimer's disease: A commentary on recent findings 139
Anorexia Heralding the Onset of Neuromyelitis Optica 139
Acute refractory intestinal pseudo-obstruction in MELAS : Efficacy of prucalopride 138
A Neurometabolic Profile of Secondary Progressive Multiple Sclerosis: The Relationship between Brain Metabolites and Clinical Disability 136
Serum growth differentiation factor-15, glial fibrillary acidic protein, and neurofilament light chain: Their link and role in Creutzfeldt-Jakob disease 135
Antiphospholipid antibodies: a possible biomarker of disease activity in multiple sclerosis and neuromyelitis optica spectrum disorders 132
Atlantoaxial subluxation in rheumatoid arthritis 131
A case of hemorrhagic Wernicke's encephalopathy following gastric surgery 127
A longitudinal study of spinal cord atrophy in progressive multiple sclerosis 127
Clinical and biological underpinnings of longitudinal atrophy pattern progression in Alzheimer's disease 124
Association between Anemia and Multiple Sclerosis 122
Investigating interleukin-8 in Alzheimer's disease: a comprehensive review 121
Interferon-beta therapy and risk of thrombocytopenia in multiple sclerosis patients 121
Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis 117
A new national survey of centers for cognitive disorders and dementias in Italy 115
CD4(+)T-bet(+), CD4(+)pSTAT3(+) and CD8(+)T-bet(+) T cells accumulate in peripheral blood during NZB treatment 114
Brainstem and spinal cord involvement in a paraneoplastic syndrome associated with anti-Yo antibody and breast cancer 112
Systematic assessment and characterization of chronic pain in multiple sclerosis patients 112
The Role of TNF-α in Alzheimer’s Disease: A Narrative Review 111
Natural killer lymphocytes in HIV and multiple sclerosis 110
Pharmacotherapy in Secondary Progressive Multiple Sclerosis: An Overview 108
Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review 108
Clinical and MRI Predictors of Conversion From Mild Behavioural Impairment to Dementia 107
Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments 106
CD8+effector and memory T cell subsets in relapsing-onset Multiple Sclerosis 106
Current Evidence Supporting the Role of Immune Response in ATTRv Amyloidosis 105
Second-line therapy with fingolimod for relapsing-remitting multiple sclerosis in clinical practice: the effect of previous exposure to natalizumab 105
Brain perfusion by arterial spin labeling MRI in multiple sclerosis 105
Riboflavin in Neurological Diseases: A Narrative Review 105
CD8(+)Foxp3(+) T cells in peripheral blood of relapsing-remitting multiple sclerosis patients 104
Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial 103
Retinal nerve fibre layer thickness in the temporal quadrant predicts clinical disability and cervical cord cross sectional area in secondary progressive multiple sclerosis 103
Is There a Role of Vitamin D in Alzheimer's disease? 103
NAA is a Marker of Disability in Secondary-Progressive MS: A Proton MR Spectroscopic Imaging Study 102
Vascular risk factors are associated with grey matter atrophy in secondary progressive multiple sclerosis 101
HIV and decreased risk of multiple sclerosis: role of low CD4+ lymphocyte count and male prevalence 100
Inflammatory profile in mitochondrial diseases: a cohort study 99
HIV and lower risk of multiple sclerosis: role of adaptive immune response 99
Paraneoplastic Morvan's syndrome following surgical treatment of recurrent thymoma: A case report 98
PPIs as possible risk factor for copper deficiency myelopathy 98
Circulating CD8(+)CD56(-)perforin(+) T cells are increased in multiple sclerosis patients 98
Systematic assessment and characterization of chronic pain in multiple sclerosis patients 98
Teaching NeuroImages: A case of hearing loss in a paraneoplastic syndrome associated with anti-Hu antibody 98
Neurofilament heavy chain in secondary progressive multiple sclerosis 97
Increased CD4(+)CD25(+)Foxp3(+) T cells in peripheral blood of celiac disease patients: Correlation with dietary treatment 97
Concurrence of multiple sclerosis and brain tumors 97
Multiple Sclerosis Impact Scale and brain volume are independent predictors of cognitive impairment in Secondary Progressive Multiple Sclerosis 97
Type 1 immune response in progressive multiple sclerosis 96
Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis 96
Optical coherence tomography in secondary progressive multiple sclerosis: a baseline data report from the MS-SMART trial 96
Tumefactive Demyelinating Lesions and Pregnancy 95
Osteoma of the Internal Auditory Canal 95
Paroxysmal ataxia and dysarthria in multiple sclerosis 95
MTR-derived pial and subpial abnormalities in the spinal cord of RRMS patients: a two-year follow-up study 95
Cerebellar degeneration associated with mGluR1 autoantibodies as a paraneoplastic manifestation of prostate adenocarcinoma 94
Dimethyl fumarate may still have a role in progressive multiple sclerosis 94
Secondary Progressive Multiple Sclerosis: Definition and Measurement 94
Initial cross-sectional MR spectroscopy analysis of a cohort of secondary progressive MS patients enrolled in the MS-SMART trial 94
The detection of neural autoantibodies in patients with antiepileptic- drug-resistant epilepsy predicts response to immunotherapy 93
Optical coherence tomography in secondary progressive multiple sclerosis: cross-sectional and longitudinal exploratory analysis from the MS-SMART randomised controlled trial 92
Midbrain Panda Sign in a Patient with Wilsons Disease 92
Reply [a: Influenza A (H1N1) in cerebrospinal fluid sample and encephalopathy by Sandoval-Gutiérrez JM, Arcos M, Alva L, Volkow P, T Ferrari T, Quiñones F, Vázquez-Pérez J, Ormsby JE, Hanssen F, Reséndiz A, Alcántara P, Pérez Padilla R, Bautista E] 92
Commentary: Tumefactive Demyelinating Lesions as a First Clinical Event: Clinical, Imaging, and Follow-up Observations 92
Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies 92
Psychological General Well-being, Cognitive Failure, and Inflammation Biomarkers Among Workers 4 Months After a Mild/Asymptomatic SARS-CoV-2 Infection 91
Teaching NeuroImages: Basal ganglia involvement in facio-brachial dystonic seizures associated with LGI1 antibodies 91
Examining cross-sectional relationships of optical coherence tomography, cervical cord MRI and disability in secondary progressive MS 91
Brain reserve and physical disability in secondary progressive multiple sclerosis 89
Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet 89
Corrigendum: A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis 89
Neuroradiological characterization of multiple sclerosis patients with chronic pain 89
Investigating the impact of different dichotomous definitions for cognitive impairment on functional connectivity in secondary progressive MS 88
Systematic assessment and characterization of chronic pain in multiple sclerosis patients: preliminary results 87
Spinal cord area is a stronger predictor of physical disability than brain volume in secondary progressive Multiple Sclerosis 87
Distinct lymphocytes subsets in IgM-related neuropathy: clinical-immunological correlations 86
Totale 12.282
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.129
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.129
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.132 0 0 290 214 59 22 7 90 43 29 76 302
2022/20231.358 133 129 174 170 81 249 45 82 152 94 24 25
2023/2024840 44 28 35 21 18 223 288 14 5 18 20 126
2024/20252.629 88 148 170 133 279 156 53 143 211 173 256 819
2025/20267.422 488 948 1.053 852 1.021 209 735 304 298 369 368 777
2026/2027925 701 224 0 0 0 0 0 0 0 0 0 0
Totale 14.306